FI943773A0 - Uudet makrosykliset laktonit ja niitä tuottava kanta - Google Patents
Uudet makrosykliset laktonit ja niitä tuottava kantaInfo
- Publication number
- FI943773A0 FI943773A0 FI943773A FI943773A FI943773A0 FI 943773 A0 FI943773 A0 FI 943773A0 FI 943773 A FI943773 A FI 943773A FI 943773 A FI943773 A FI 943773A FI 943773 A0 FI943773 A0 FI 943773A0
- Authority
- FI
- Finland
- Prior art keywords
- macrocyclic lactones
- hydroxy
- hydrogen
- methoxy
- ferm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
- C12R2001/55—Streptomyces hygroscopicus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2966992 | 1992-02-17 | ||
PCT/US1993/001087 WO1993016189A1 (en) | 1992-02-17 | 1993-02-11 | Novel macrocyclic lactones and a productive strain thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
FI943773A0 true FI943773A0 (fi) | 1994-08-16 |
FI943773A FI943773A (fi) | 1994-08-16 |
Family
ID=12282523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI943773A FI943773A (fi) | 1992-02-17 | 1994-08-16 | Uudet makrosykliset laktonit ja niitä tuottava kanta |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0627009B1 (fi) |
JP (1) | JP3140228B2 (fi) |
AT (1) | ATE145429T1 (fi) |
AU (1) | AU3658693A (fi) |
CA (1) | CA2128529A1 (fi) |
DE (1) | DE69306102T2 (fi) |
DK (1) | DK0627009T3 (fi) |
ES (1) | ES2095044T3 (fi) |
FI (1) | FI943773A (fi) |
GR (1) | GR3022309T3 (fi) |
IL (1) | IL104652A0 (fi) |
MX (1) | MX9300804A (fi) |
WO (1) | WO1993016189A1 (fi) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT98990A (pt) * | 1990-09-19 | 1992-08-31 | American Home Prod | Processo para a preparacao de esteres de acidos carboxilicos de rapamicina |
GB9103430D0 (en) | 1991-02-19 | 1991-04-03 | Smithkline Beecham Plc | Novel compound |
ZA935110B (en) * | 1992-07-17 | 1994-02-04 | Smithkline Beecham Corp | Rapamycin derivatives |
ZA935111B (en) * | 1992-07-17 | 1994-02-04 | Smithkline Beecham Corp | Rapamycin derivatives |
ZA935112B (en) * | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
GB9302569D0 (en) * | 1993-02-10 | 1993-03-24 | Smithkline Beecham Plc | Novel compound |
USRE37421E1 (en) | 1993-07-16 | 2001-10-23 | Smithkline Beecham Corporation | Rapamycin derivatives |
WO1995014023A1 (en) * | 1993-11-19 | 1995-05-26 | Abbott Laboratories | Semisynthetic analogs of rapamycin (macrolides) being immunomodulators |
US5527907A (en) * | 1993-11-19 | 1996-06-18 | Abbott Laboratories | Macrolide immunomodulators |
WO1996006847A1 (en) * | 1994-08-31 | 1996-03-07 | Pfizer Inc. | Process for preparing demethylrapamycins |
EP1244800B1 (en) * | 1999-10-29 | 2007-03-14 | Kosan Biosciences, Inc. | Rapamycin analogs |
LT3351246T (lt) * | 2001-02-19 | 2019-07-10 | Novartis Pharma Ag | Rapamicino darinys, skirtas kieto naviko, susijusio su nereguliuojama angiogeneze, gydymui |
KR100431573B1 (ko) * | 2002-03-12 | 2004-05-17 | 한국해양연구원 | 방선균 유래의 신규 생리 활성 물질, 이의 추출 방법 및이를 포함하는 약학적 조성물 |
ES2544624T3 (es) | 2002-07-16 | 2015-09-02 | Buck Institute For Research On Aging | Producción de policétidos |
WO2004101803A2 (en) | 2003-05-12 | 2004-11-25 | Wyeth Holdings Corporation | Process for producing anticancer agent ll-d45042 |
GB0504994D0 (en) | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Novel compounds |
GB0504995D0 (en) | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Use of a compound |
BRPI0716950A2 (pt) | 2006-09-13 | 2013-10-29 | Elixir Medical Corp | Composição farmacêutica, dispositivo para uso intracorpóreo, método para inibir proliferação celular, composto, e, método para preparar um composto |
US8088789B2 (en) | 2006-09-13 | 2012-01-03 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
US10695327B2 (en) | 2006-09-13 | 2020-06-30 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
WO2012150543A1 (en) | 2011-05-02 | 2012-11-08 | Universite De Geneve | Macrocyclic lactones and use thereof |
WO2016139331A1 (en) | 2015-03-05 | 2016-09-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of melanoma |
WO2017144546A1 (en) | 2016-02-23 | 2017-08-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of nasopharyngeal carcinoma |
US20220220480A1 (en) | 2019-04-17 | 2022-07-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treatment of nlrp3 inflammasome mediated il-1beta dependent disorders |
KR102199005B1 (ko) * | 2019-12-13 | 2021-01-06 | 전남대학교산학협력단 | 휴미콜라 속 js-0112 균주 및 이를 함유하는 항진균제 조성물 |
WO2021198511A1 (en) | 2020-04-03 | 2021-10-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treatment of sars-cov-2 infection |
WO2022008597A1 (en) | 2020-07-08 | 2022-01-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical composition for the treatment of infectious diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
GB9103430D0 (en) * | 1991-02-19 | 1991-04-03 | Smithkline Beecham Plc | Novel compound |
US5091389A (en) * | 1991-04-23 | 1992-02-25 | Merck & Co., Inc. | Lipophilic macrolide useful as an immunosuppressant |
-
1992
- 1992-12-02 JP JP04323407A patent/JP3140228B2/ja not_active Expired - Fee Related
-
1993
- 1993-02-08 IL IL104652A patent/IL104652A0/xx unknown
- 1993-02-11 AU AU36586/93A patent/AU3658693A/en not_active Abandoned
- 1993-02-11 DK DK93905810.3T patent/DK0627009T3/da active
- 1993-02-11 DE DE69306102T patent/DE69306102T2/de not_active Expired - Fee Related
- 1993-02-11 ES ES93905810T patent/ES2095044T3/es not_active Expired - Lifetime
- 1993-02-11 CA CA002128529A patent/CA2128529A1/en not_active Abandoned
- 1993-02-11 WO PCT/US1993/001087 patent/WO1993016189A1/en active IP Right Grant
- 1993-02-11 EP EP93905810A patent/EP0627009B1/en not_active Expired - Lifetime
- 1993-02-11 AT AT93905810T patent/ATE145429T1/de not_active IP Right Cessation
- 1993-02-15 MX MX9300804A patent/MX9300804A/es unknown
-
1994
- 1994-08-16 FI FI943773A patent/FI943773A/fi unknown
-
1997
- 1997-01-16 GR GR970400070T patent/GR3022309T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69306102T2 (de) | 1997-03-13 |
MX9300804A (es) | 1994-07-29 |
EP0627009A1 (en) | 1994-12-07 |
JPH05292948A (ja) | 1993-11-09 |
EP0627009B1 (en) | 1996-11-20 |
ATE145429T1 (de) | 1996-12-15 |
AU3658693A (en) | 1993-09-03 |
DE69306102D1 (de) | 1997-01-02 |
ES2095044T3 (es) | 1997-02-01 |
DK0627009T3 (da) | 1997-05-05 |
CA2128529A1 (en) | 1993-08-19 |
GR3022309T3 (en) | 1997-04-30 |
WO1993016189A1 (en) | 1993-08-19 |
JP3140228B2 (ja) | 2001-03-05 |
FI943773A (fi) | 1994-08-16 |
IL104652A0 (en) | 1993-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI943773A (fi) | Uudet makrosykliset laktonit ja niitä tuottava kanta | |
CY1816A (en) | BMY - 41950 antitumor antibiotic | |
DE3378059D1 (en) | Antitumor antibiotics | |
AU4979085A (en) | Cl-1577d, 1557e antibiotic/antitumor compounds | |
SE7709234L (sv) | Antitumorantibiotika | |
WO2001074850A1 (fr) | Antibiotiques tripropeptines et leur procede de production | |
EP0491956A4 (en) | Reveromycin a, production thereof, and antitumor drug and fungicide | |
EP0376609A3 (en) | Antibiotic a80915 and process for its production | |
SE8304132D0 (sv) | Antitumor-antibiotikum | |
DK64784A (da) | 19-epi-dianemycin, fremgangsmaade til fremstilling deraf, anvendelse deraf som anticoccidialt og antibakterielt middel og kultur af mikroorganismen streptomyces hygroscopicus atcc 39205 | |
AU2283492A (en) | Antibiotic ll-e19020 alpha1 | |
DE69217597D1 (de) | Antibiotikum LL-E19020 Epsilon und LL-E19029 Epsilon 1 | |
AU2283092A (en) | Antibiotic ll-e19020 gamma | |
CA2158482A1 (en) | UCF1 Compounds, Derivatives Thereof and Processes for Their Preparation | |
KR960008662B1 (en) | New anti-cancer diperpene compound | |
MX9605773A (es) | Compuestos de cefalosporina y procesos para la preparacion de los mismos. | |
ES2060962T3 (es) | Antibioticos glicopeptidicos. | |
MX9701853A (es) | Antibiotico especifico de legionella, micro-organismo que produce el antibiotico y proceso para producir el mismo. |